Ocular Therapeutix (OCUL) earnings, Aug 3, 2026: EPS +10%, stock +2.8%
In brief
Ocular Therapeutix reported on Aug 3, 2026. Earnings per share changed +10% year over year, 11.5% above the estimate; revenue 0%. The stock opened with a +1.4% gap and closed the day +2.8% (Aug 3, 2026). The stock is now 60.9% below its 52-week high, −40.5% over 12 months. Next report: Nov 9, 2026.
EPS vs estimate+11.5%
EPS, YoY+10%
Revenue, YoY0%
Gap · day+1.4% · +2.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 3, 2026 | +1.4% | +2.8% |
Next-quarter estimates, ratings and the OCUL chart are in the terminal.
Open the terminalFAQ
When is Ocular Therapeutix's next earnings report?
Nov 9, 2026. The date comes from daily data and is corrected if the company moves it.
How did Ocular Therapeutix stock react to the report?
Opening gap +1.4%, day's result +2.8%.
Did Ocular Therapeutix's earnings grow?
Earnings per share rose 10% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.